Search Results - "Oosterwijk, Jan"

"It Is What It Is" by Oosterwijk, Jan C

Get full text

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial by Saadatmand, Sepideh, MD, Geuzinge, H Amarens, MSc, Rutgers, Emiel J T, Prof, Mann, Ritse M, MD, de Roy van Zuidewijn, Diderick B W, MD, Zonderland, Harmien M, MD, Tollenaar, Rob A E M, Prof, Lobbes, Marc B I, MD, Ausems, Margreet G E M, MD, van 't Riet, Martijne, MD, Hooning, Maartje J, MD, Mares-Engelberts, Ingeborg, MD, Luiten, Ernest J T, MD, Heijnsdijk, Eveline A M, PhD, Verhoef, Cees, Prof, Karssemeijer, Nico, PhD, Oosterwijk, Jan C, MD, Obdeijn, Inge-Marie, MD, de Koning, Harry J, Prof, Tilanus-Linthorst, Madeleine M A, MD

“…SummaryBackgroundApproximately 15% of all breast cancers occur in women with a family history of breast cancer, but for whom no causative hereditary gene…”
Get full text

CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism by van der Tuin, Karin, Tops, Carli M J, Adank, Muriel A, Cobben, Jan-Maarten, Hamdy, Neveen A T, Jongmans, Marjolijn C, Menko, Fred H, van Nesselrooij, Bernadette P M, Netea-Maier, Romana T, Oosterwijk, Jan C, Valk, Gerlof D, Wolffenbuttel, Bruce H R, Hes, Frederik J, Morreau, Hans

“…Abstract Context Heterozygous pathogenic germline variants in CDC73 predispose to the development of primary hyperparathyroidism (pHPT) and, less frequently,…”
Get full text

Support of the ‘fallopian tube hypothesis’ in a prospective series of risk-reducing salpingo-oophorectomy specimens by Reitsma, Welmoed, de Bock, Geertruida H, Oosterwijk, Jan C, Bart, Joost, Hollema, Harry, Mourits, Marian J.E

“…Abstract Objective To determine the prevalence, localisation and type of occult (non)invasive cancer in risk-reducing salpingo-oophorectomy (RRSO) specimens in…”
Get full text

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC) by Saadatmand, Sepideh, Obdeijn, Inge‐Marie, Rutgers, Emiel J., Oosterwijk, Jan C., Tollenaar, Rob A., Woldringh, Gwendolyn H., Bergers, Elisabeth, Verhoef, Cornelis, Heijnsdijk, Eveline A., Hooning, Maartje J., de Koning, Harry J., Tilanus‐Linthorst, Madeleine M.

“…Adding MRI to annual mammography screening improves early breast cancer detection in women with familial risk or BRCA1/2 mutation, but breast cancer specific…”
Get full text

PRDM10 directs FLCN expression in a novel disorder overlapping with Birt–Hogg–Dubé syndrome and familial lipomatosis by van de Beek, Irma, Glykofridis, Iris E, Oosterwijk, Jan C, van den Akker, Peter C, Diercks, Gilles F H, Bolling, Maria C, Waisfisz, Quinten, Mensenkamp, Arjen R, Balk, Jesper A, Zwart, Rob, Postma, Alex V, Meijers-Heijboer, Hanne E J, van Moorselaar, R Jeroen A, Wolthuis, Rob M F, Houweling, Arjan C

“…Abstract Birt–Hogg–Dubé syndrome (BHD) is an autosomal dominant disorder characterized by fibrofolliculomas, pulmonary cysts, pneumothoraces and renal cell…”
Get full text

BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study by RIJNSBURGER, Adriana J, OBDEIJN, Inge-Marie, PETERSE, Hans, TOLLENAAR, Rob A. E. M, HOOGERBRUGGE, Nicoline, MEIJER, Sybren, BARTELS, Carina C. M, SEYNAEVE, Caroline, HOONING, Maartje J, KRIEGE, Mieke, SCHMITZ, Paul I. M, OOSTERWIJK, Jan C, KAAS, Reinoutje, DE KONING, Harry J, RUTGERS, Emiel J. T, KLIJN, Jan G. M, TILANUS-LINTHORST, Madeleine M. A, BOETES, Carla, LOO, Claudette E, WASSER, Martin N. J. M, BERGERS, Elisabeth, KOK, Theo, MULLER, Sara H

“…The Dutch MRI Screening Study on early detection of hereditary breast cancer started in 1999. We evaluated the long-term results including separate analyses of…”
Get full text

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age by van der Kolk, Dorina M, de Bock, Geertruida H, Leegte, Beike K, Schaapveld, Michael, Mourits, Marian J. E, de Vries, Jakob, van der Hout, Annemieke H, Oosterwijk, Jan C

“…Accurate estimations of lifetime risks of breast and ovarian cancer are crucial for counselling women from BRCA1/2 families. We therefore determined breast and…”
Get full text

Genetic control of tumor development in malformation syndromes by Postema, Floor A.M., Oosterwijk, Jan C., Hennekam, Raoul C.

“…One of the questions that arises frequently when caring for an individual with a malformation syndrome, is whether some form of tumor surveillance is…”
Get full text

A Capacity-Achieving Simple Decoder for Bias-Based Traitor Tracing Schemes by Oosterwijk, Jan-Jaap, Skoric, Boris, Doumen, Jeroen

“…We investigate alternative suspicion functions for bias-based traitor tracing schemes, and present a practical construction of a simple decoder that attains…”
Get full text

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers by Yang, Xin, Mooij, Thea M, Leslie, Goska, Ficorella, Lorenzo, Andrieu, Nadine, Kast, Karin, Singer, Christian F, Jakubowska, Anna, van Gils, Carla H, Tan, Yen Y, Engel, Christoph, Adank, Muriel A, van Asperen, Christi J, Ausems, Margreet G E M, Berthet, Pascaline, Collee, Margriet J, Cook, Jackie A, Eason, Jacqueline, Spaendonck-Zwarts, Karin Y van, Evans, D Gareth, Gómez García, Encarna B, Hanson, Helen, Izatt, Louise, Kemp, Zoe, Lalloo, Fiona, Lasset, Christine, Lesueur, Fabienne, Musgrave, Hannah, Nambot, Sophie, Noguès, Catherine, Oosterwijk, Jan C, Stoppa-Lyonnet, Dominique, Tischkowitz, Marc, Tripathi, Vishakha, Wevers, Marijke R, Zhao, Emily, van Leeuwen, Flora E, Schmidt, Marjanka K, Easton, Douglas F, Rookus, Matti A, Antoniou, Antonis C

“…No validation has been conducted for the BOADICEA multifactorial breast cancer risk prediction model specifically in pathogenic variant (PV) carriers to date…”
Get more information

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer by Fakkert, Ingrid E, van der Veer, Eveline, Abma, Elske Marije, Lefrandt, Joop D, Wolffenbuttel, Bruce H R, Oosterwijk, Jan C, Slart, Riemer H J A, Westrik, Iris G, de Bock, Geertruida H, Mourits, Marian J E

“…Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA1/2 mutation carriers. Premenopausal RRSO is hypothesized to increase fracture…”
Get full text

Multiple tumors due to mosaic genome‐wide paternal uniparental disomy by Postema, Floor A.M., Bliek, Jet, Noesel, Carel J.M., Zutven, Laura J.C.M., Oosterwijk, Jan C., Hopman, Saskia M. J., Merks, Johannes H. M., Hennekam, Raoul C.

“…Mosaic genome‐wide paternal uniparental disomy is an infrequently described disorder in which affected individuals have signs and symptoms that may resemble…”
Get full text

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition by Kriege, Mieke, Brekelmans, Cecile T.M, Boetes, Carla, Besnard, Peter E, Zonderland, Harmine M, Obdeijn, Inge Marie, Manoliu, Radu A, Kok, Theo, Peterse, Hans, Tilanus-Linthorst, Madeleine M.A, Muller, Sara H, Meijer, Sybren, Oosterwijk, Jan C, Beex, Louk V.A.M, Tollenaar, Rob A.E.M, de Koning, Harry J, Rutgers, Emiel J.T, Klijn, Jan G.M

“…In a comparison of mammography with magnetic resonance imaging (MRI) for screening women at high risk for breast cancer, MRI was more sensitive but less…”
Get full text

Binary and q-ary Tardos codes, revisited by Škorić, Boris, Oosterwijk, Jan-Jaap

“…The Tardos code is a much studied collusion-resistant fingerprinting code, with the special property that it has asymptotically optimal length m ∝ c 0 2 ,…”
Get full text

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined by HEIJNSDIJK, Eveline A. M, WARNER, Ellen, WARREN, Ruth M. L, HILL, Kimberly A, HOOGERBRUGGE, Nicoline, WASSER, Martin N. J. M, BERGERS, Elisabeth, OOSTERWIJK, Jan C, HOONING, Maartje J, RUTGERS, Emiel J. T, KLIJN, Jan G. M, PLEWES, Don B, GILBERT, Fiona J, LEACH, Martin O, DE KONING, Harry J, TILANUS-LINTHORST, Madeleine M. A, EVANS, Gareth, CAUSER, Petrina A, EELES, Rosalind A, KAAS, Reinie, DRAISMA, Gerrit, RAMSAY, Elizabeth A

“…It is recommended that BRCA1/2 mutation carriers undergo breast cancer screening using MRI because of their very high cancer risk and the high sensitivity of…”
Get full text

Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced? by van Tilborg, Theodora C., Derks-Smeets, Inge A.P., Bos, Anna M.E., Oosterwijk, Jan C., van Golde, Ron J., de Die-Smulders, Christine E., van der Kolk, Lizet E., van Zelst-Stams, Wendy A.G., Velthuizen, Maria E., Hoek, Annemieke, Eijkemans, Marinus J.C., Laven, Joop S.E., Ausems, Margreet G.E.M., Broekmans, Frank J.M.

“…STUDY QUESTION Do BRCA1/2 mutation carriers have a compromised ovarian reserve compared to proven non-carriers, based on serum anti-Müllerian hormone (AMH)…”
Get full text

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers by Vos, Janet R, Hsu, Li, Brohet, Richard M, Mourits, Marian J E, de Vries, Jakob, Malone, Kathleen E, Oosterwijk, Jan C, de Bock, Geertruida H

“…Recommendations for treating patients who carry a BRCA1/2 gene are mainly based on cumulative lifetime risks (CLTRs) of breast cancer determined from…”
Get full text

Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance Imaging by SAADATMAND, Sepideh, TILANUS-LINTHORST, Madeleine M. A, DE KONING, Harry J, RUTGERS, Emiel J. T, HOOGERBRUGGE, Nicoline, OOSTERWIJK, Jan C, TOLLENAAR, Rob A. E. M, HOONING, Maartje, LOO, Claudette E, OBDEIJN, Inge-Marie, HEIJNSDIJK, Eveline A. M

“…To reduce mortality, women with a family history of breast cancer are often screened with mammography before age 50 years. Additional magnetic resonance…”
Get full text

Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer by Fakkert, Ingrid E, Abma, Elske Marije, Westrik, Iris G, Lefrandt, Joop D, Wolffenbuttel, Bruce H.R, Oosterwijk, Jan C, Slart, Riemer H.J.A, van der Veer, Eveline, de Bock, Geertruida H, Mourits, Marian J.E

“…Abstract Aim Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA mutation carriers. RRSO is assumed to decrease bone mineral density…”
Get full text